What is the new Langya virus that has infected dozens in China
A new virus has infected dozens of people in China, with researchers suggesting shrews might be a “natural reservoir” for the virus. Research published in […]
A new virus has infected dozens of people in China, with researchers suggesting shrews might be a “natural reservoir” for the virus. Research published in […]
El medicamento, de Eli Lilly, ya se emplea para la artritis reumatoide y, en muchos pacientes, restablece el crecimiento del cabello. Pronto podría haber otros […]
El medicamento, de Eli Lilly, ya se emplea para la artritis reumatoide y, en muchos pacientes, restablece el crecimiento del cabello. Pronto podría haber otros […]
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies.
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies.
For some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment halted their cancer’s growth.
El estudio era pequeño y los expertos dicen que hay que replicarlo. Pero para 18 pacientes oncológicos, el resultado produjo “lágrimas de felicidad”.
The study was small, and experts say it needs to be replicated. But for 18 people with colorectal cancer, the outcome led to “happy tears.”
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
The panel debated whether overseas trials could be applied to a more diverse U.S. population. The decision may affect other Chinese drug trials, and spotlights […]
The panel debated whether overseas trials could be applied to a more diverse U.S. population. The decision may affect other Chinese drug trials, and spotlights […]
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments.
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments.
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments.
In an alert on Friday, the Food and Drug Administration warmed that pulse oximeters might be inaccurate in some circumstances. The agency listed skin color […]
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Shots: The P-II BLAZE-1 study assesses bamlanivimab (700, 2800 & 7000 mg) vs PBO in the outpatient setting in patients with mild or moderate symptoms […]
Copyright © 2024 | WordPress Theme by MH Themes